SK bioscience Co.,Ltd.
KRX:302440.KS
48950 (KRW) • At close January 15, 2025
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) KRW.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||
| Nettowinst
| 22,317.718 | 122,451.95 | 355,139.277 | 32,889.712 | 14,677.405 | 420.845 |
| Afschrijvingen & Amortisatie
| 34,764.703 | 27,236.409 | 18,775.305 | 16,527.436 | 14,543.238 | 6,594.926 |
| Uitgestelde Inkomstenbelasting
| 0 | 0 | 0 | -719.864 | -5,587.062 | 4,327.733 |
| Aandelen Gebaseerde Vergoedingen
| 0 | 0 | 0 | 575.454 | 300.237 | 25.02 |
| Verandering in Werkkapitaal
| -18,391.696 | -208,378.665 | 44,000.929 | 66,407.706 | 8,061.487 | 1,114.223 |
| Vorderingen
| 26,673.86 | -44,647.416 | -398.647 | -14,609.697 | 12,254.972 | -12,664.522 |
| Voorraden
| 52,888.273 | -96,229.843 | -70,337.103 | -31,573.385 | -6,887.871 | 6,876.125 |
| Crediteuren
| 0 | -52,758.718 | 46,536.207 | -866.886 | 7,295.049 | -7,029.846 |
| Overig Werkkapitaal
| -97,953.829 | -14,742.688 | 68,200.472 | 113,457.674 | -4,600.663 | -5,761.902 |
| Overige Niet-Contante Posten
| -9,344.364 | -66,267.978 | 118,678.177 | 4,543.347 | 3,977.22 | 2,419.772 |
| Kasstroom uit Operationele Activiteiten
| 29,346.361 | -124,958.284 | 536,593.688 | 120,223.791 | 35,972.525 | 14,902.519 |
| Investeringsactiviteiten: | ||||||
| Investeringen in Materiële Vaste Activa
| -50,295.489 | -76,489.443 | -44,469.56 | -10,197.57 | -23,968.408 | -6,309.972 |
| Netto Overnames
| 0 | 34.566 | 5,819.51 | 197.839 | 99.922 | 0 |
| Aankoop van Beleggingen
| -111,396.35 | -1,000.087 | -1,385,607.013 | -102,396.742 | -99.922 | -11,323.366 |
| Verkoop/verval van Beleggingen
| 118,773.445 | 353,052.205 | 990 | 3,262.04 | 21,019.983 | 0 |
| Overige Investeringsactiviteiten
| -2,360.327 | -2,950.736 | 1,326.778 | 1,041.516 | 302.465 | -9.16 |
| Kasstroom uit Investeringsactiviteiten
| -45,278.721 | 272,646.505 | -1,421,940.285 | -108,092.918 | -2,645.959 | -17,642.498 |
| Financieringsactiviteiten: | ||||||
| Schuldaflossingen
| -83,553.994 | -55,031.22 | -22,410.369 | -1,237.367 | -23,435.486 | -10,000 |
| Uitgifte van Gewone Aandelen
| 397.599 | 2,617.946 | 983,255.829 | -301.455 | 0 | 10,981.864 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| -6,426.221 | 32,546.113 | -2,465.174 | 0 | 0 | -144 |
| Kasstroom uit Financieringsactiviteiten
| -89,582.616 | -19,867.162 | 958,380.287 | -1,538.822 | -23,435.486 | 837.864 |
| Overige Informatie: | ||||||
| Effect van Wisselkoersveranderingen op Kas
| 7,253.167 | -561.871 | 22.252 | 0 | 0 | -0 |
| Netto Kasstroomverandering
| -98,261.81 | 127,259.187 | 73,055.941 | 10,592.051 | 9,891.079 | -1,902.116 |
| Kaspositie aan het Einde van de Periode
| 127,025.639 | 225,287.448 | 98,028.261 | 24,972.321 | 14,380.269 | 4,489.19 |